GSK’s FIRST Trial Meets Primary Endpoint: Dostarlimab Plus Niraparib Shows Progression-Free Survival Benefit in First-Line Advanced Ovarian Cancer 2 years ago AnaIn Breaking NewsPharma Industry UpdatesTop Stories
AI Drug Discovery Hits Milestone as First Fully Machine-Designed Molecule Enters Phase 2 2 years ago AnaIn AI & DataBiopharma HighlightsClinical TrialsResearch Updates
Psychedelic Therapies Edge Toward Mainstream as Phase 3 Trials Expand Globally 2 years ago AnaIn Breaking NewsClinical TrialsFDA Approvals
FDA Approves First MSC Therapy for Pediatric GvHD as PepGen Faces Clinical Hold in DMD Trial 2 years ago AnaIn Clinical TrialsFDA Approvals
Lepu Biopharma Licenses T-Cell Engagers to Excalipoint in $857M Deal, Expanding China’s Immunotherapy Footprint 2 years ago AnaIn PartnershipsPeopleTop StoriesVenture Capital
Dexcom Unveils AI-Enhanced Glucose Monitor for OTC Use, Pushing FDA Boundaries 2 years ago AnaIn BreakthroughsClinical TrialsFDA Approvals
Cellarity’s AI-Designed Cell Therapy Enters Phase 1 for Solid Tumors, Backed by $250M Series D 2 years ago AnaIn Biopharma HighlightsClinical TrialsInvestmentsVenture Capital
Pragmatic Trials, Real-World Impact: NIH’s 2024 Push to Redefine Clinical Research 2 years ago AnaIn BreakthroughsFeatured AnalysisLeadersTop Stories
FDA Approves Depemokimab for Severe Eosinophilic Asthma: A Win for Rare Disease Innovation 2 years ago AnaIn BreakthroughsFDA ApprovalsPharma Industry Updates
mRNA-Based RSV Vaccine Shows Strong Efficacy in Older Adults: Moderna’s Candidate Advances Toward Approval 2 years ago AnaIn Biopharma HighlightsBreaking NewsClinical Trials
Atezolizumab Shows Promise in Rare Thyroid Cancer: Roche’s Immunotherapy Gains Ground in RET-Altered Tumors 2 years ago AnaIn Clinical TrialsLeadersResearch Updates
Duchenne Disappointment: Pfizer Halts Phase III Trial of Gene Therapy for DMD After Missed Endpoints 2 years ago AnaIn Breaking NewsClinical Trials
GLP-1 Agonists Show Cardiovascular Benefit Beyond Diabetes: Novo Nordisk’s Semaglutide Hits New Milestone 2 years ago AnaIn Breaking NewsInnovationPharma Industry UpdatesTop Stories
FDA Greenlights Psychedelic Therapy Trial for PTSD: COMPASS Pathways Moves Forward with Phase III Psilocybin Study 2 years ago AnaIn FDA ApprovalsResearch UpdatesTop Stories
Depemokimab Shows Promise in Severe Asthma: GSK’s IL-5 Inhibitor Hits Key Phase III Milestone 2 years ago AnaIn Pharma Industry UpdatesResearch UpdatesTop Stories
